Skip to main content

Table 3 Covariates associated with prescription of an anti-malarial drug among children with only negative malaria tests results

From: Anti-malarial prescription practices among children admitted to six public hospitals in Uganda from 2011 to 2013

Covariates Proportion prescribed an antimalarial (%) Univariate analysis Multivariate analysis
OR 95 % CI p value aOR 95 % CI p value
Hospital
 Kabale 513/3544 (14.5)   Reference    Reference  
 Tororo 1154/5541 (20.8) 1.55 1.39-1.74 <0.001 1.72 1.44-2.04 <0.001
 Apac 814/2841 (28.7) 2.37 2.10-2.69 <0.001 2.69 2.23-3.24 <0.001
 Kambuga 877/2196 (39.9) 3.93 3.46-4.46 <0.001 3.39 2.88-4.00 <0.001
 Jinja 5661/10,571 (53.6) 6.81 6.16-7.54 <0.001 7.45 6.37-8.71 <0.001
 Mubende 2958/5517 (53.6) 6.83 6.13-7.60 <0.001 7.19 6.17-8.39 <0.001
Age
 <6 months 692/4062 (17.0)   Reference    Reference  
 6–12 months 2440/6272 (38.9) 3.10 2.82–3.41 <0.001 3.82 3.43–4.26 <0.001
 ≥12 months 8840/19,866 (44.5) 3.90 3.58–4.26 <0.001 4.89 4.45–5.41 <0.001
Fevera
 Absent 487/3982 (12.2)   Reference    Reference  
 Present 11,490/26,216 (43.8) 5.60 5.08–6.18 <0.001 5.41 4.86–6.02 <0.001
Clinical findings suggestive of complicated malariab
 Absent 4329/14,819 (29.2)   Reference    Reference  
 Present 7648/15,391 (49.7) 2.39 2.28–2.51 <0.001 1.94 1.83–2.06 <0.001
  1. Clustering on the day of admission adjusted using GEE
  2. aHistory of fever or elevated temperature
  3. bHistory of or witnessed convulsions, altered consciousness, tea coloured urine, jaundice, unconsciousness, lethargy, inability to sit, or severe pallor